InterDigital Files two Patent Infringement Cases against Xiaomi in Delhi HC

InterDigital (a US-based mobile technology research and development company specializing in providing video and wireless technologies for mobile devices, services, and networks across the globe) has quite recently filed two Patent Infringement cases against Xiaomi (a Chinese electronics company headquartered in Beijing) in the Delhi High Court. 

According to InterDigital, the Chinese phone maker has involved itself in the unauthorized use of three H.265/HEVC (High-Efficiency Video Coding) patents and five cellular 3G and 4G patents owned by InterDigital.

The company claimed that it has been in negotiation with Xiaomi for quite a while now and ended up filing the case after they couldn't reach an agreement.

InterDigital is now seeking compensatory and punitive damages against Xiaomi along with an injunction to prevent further instances of patent infringement in India unless Xiaomi agrees to a FRAND (Fair, reasonable, and non-discriminatory) license as determined by the court.

The President and CEO at InterDigital, William J. Merritt, said in a statement delivered that video and wireless standards play a crucial role in eliminating the barriers to entry, which allows new companies like Xiaomi to enter the market and emerge successfully without making any investment in previous wireless research activities. He further said that advanced research drives the key video and wireless standards, and fair licenses with companies making use of such technologies. According to him, it enables companies like InterDigital to research more, which, in turn, benefits the users and industry at large.

Huawei, Apply, and Samsung are some of the other tech giants using InterDigital's products.

The Indian patents owned by InterDigital on the cellular side, which are in contention, include the solutions enhancing utilization of cellular resources for applications (such as VoIP) that require continuous allocations of uplink resources. The other patents enable mobile users to have quick and efficient access to 4G (LTE) networks and minimize power consumption by selectively switching the handset's LTE modem to sleep mode. The patents corresponding to videos include an enhanced video decoder that reduces the network resources needed to deliver videos. Additionally, it also reduces the memory required to store videos on the handset, which leads to an improved video streaming experience. The other solution improves the picture quality for a decoded video by offering a series of filters. For view source: https://www.kashishipr.com/blog/interdigital-files-two-patent-infringement-cases-against-xiaomi-in-delhi-hc/

 

Don’t forget to follow us on social media:

Facebook – https://www.facebook.com/kashishipr/

Twitter – https://twitter.com/kashishipr

Linkedin – https://www.linkedin.com/company/kashishipr/

Pinterest – https://www.pinterest.com/kashishipr/

Tumblr – https://kashishipr.tumblr.com/

 

 

 

Contact - US

Email Id: kashishipr@kashishipr.com

Website: www.kashishipr.com

TSMC Responds to Patent Infringement Lawsuit by GlobalFoundries

TSMC, Taiwan Semiconductor Manufacturing Company, took a day to digest claims of the Patent Infringement lawsuit filed against it by GlobalFoundries (GF), one of the largest semiconductor fabrication companies worldwide, and then responded by saying that the allegations of this Intellectual Property infringement are baseless. It also proposed that the GlobalFoundries is acting like a patent troll.

TSMC added that with 37,000 granted patents globally, it has been established as one of the largest semiconductor portfolios in the industry and attained a top 10 ranking for US patent grants for 3 consecutive years since 2016. The world’s largest foundry continued that it is disappointed to see a peer opting for a meritless lawsuit rather than competing in the marketplace.

The complaint filed on 26th August 2019 by GlobalFoundaries claims that TSMC along with a number of its customers and makers of various products have infringed 16 of the GF’s patents covering several aspects of chip manufacturing. The plaintiff claimed that TSMC’s 7nm, 10 nm, 12 nm, 16 nm, and 28 nm nodes allegedly use its Intellectual Property (IP). Among defendants, the firm named Apple, MediaTek, Broadcom, NVIDIA, Xilinx, Qualcomm, and some others.

The plaintiff had filed the case in the US International Trade Commission (ITC), the Regional Courts of Dusseldorf, and Mannheim in Germany, and the U.S. Federal District Courts in the Districts of Delaware and the Western District of Texas. It is looking for damages from TSMC and wants the courts to ban the products that use infringing semiconductors in the US and Germany.

On the other side, TSMC has denied the allegations by announcing that it will defend itself in the courts. The firm stresses that it spends billions of dollars on R&D (Research and Development) every year and has been granted 37,000 patents throughout its history.

High-tech companies typically counter-sue one another in IP infringement cases, so it would not at all be surprising if TSMC chooses to sue GlobalFoundries. Although TSMC assumes that the claims are baseless and thus, planning to defend itself against GF, still if any court not necessarily but possibly disagrees, TSMC and its clients would then have to work out a royalty arrangement with GF. For view source: https://www.kashishipr.com/blog/tsmc-responds-to-patent-infringement-lawsuit-by-globalfoundries/

Don’t forget to follow us on social media:

Facebook – https://www.facebook.com/kashishipr/

Twitter – https://twitter.com/kashishipr

Linkedin – https://www.linkedin.com/company/kashishipr/

Pinterest – https://www.pinterest.com/kashishipr/

Tumblr – https://kashishipr.tumblr.com/

Patents in Pharmaceutical Industry in India

In today’s cut-throat competitive era, the pharma industry is emerging as one of the most profound ‘knowledge-driven’ sectors. As pharmaceutical researches are remarkably unpredictable and expensive, it is imperative to protect their outcomes, which can be in the form of a new and inventive product or process. Obtaining patent rights for the invented products or processes is the best method that can help pharmaceutical companies to prevent any unauthorized commercial use of their inventions. Patents, copyrights, trademarks, and geographical indication are some forms of Intellectual Property Rights (IPR). These are the rights derived to protect the Intellectual Property (IP), which is a type of intangible property created with human efforts and intellect. Patents, out of all these forms of IPR, are considered valuable to protect assets in the pharmaceutical industry.

Patent on a Drug

In the pharmaceutical industry, a patent is an IPR granted by the government to the inventor for the protection of his invention, which can be a drug or process to produce it. Note that the patent provides solutions even for several technical problems, but for getting patented, the ideas need to satisfy the criteria of patentability.

Criteria of Patentability

As per the Indian patent law, an invention is patentable if it covers a new product or process that meets the following requirements:

i) Newness/ uniqueness: The subject-matter must be unique, i.e., before the date of filing, it should neither be published in any document nor be used anywhere in the world.

ii) Inventive: The invention should involve features that make it non-obvious even to skilled persons. For instance – it should have technical advancements over the existing knowledge or economic significance or both.

iii) Industrial Applicability: The Invention should be capable of getting fit into the relevant industry. For example – a new method of excluding tumor cells from the patient’s body is not applicable industrially and thus, not patented.

Types of Pharmaceutical Patents

As discussed above, the pharma industry is an intense ‘knowledge-driven’ sector, and thus, the inventors in this sector need to be meticulous about patenting their inventions. It will be beneficial for not just the companies but also the consumers. Likewise, in other industries, patents that pertain to this sector are also country-specific. According to the Indian Patent Office, pharmaceutical patents lie under the following categories:

1. Drug Compound Patents

These are the patents that claim a drug compound as per its chemical structure and are known as Markush type claims. Intended to provide the broadest protection to the inventor of a drug, these prevent other companies from preparing a similar drug. No one is allowed to produce or sell any formulation involving this drug until the granted patent expires.

2. Synergistic Combination Patents

Drug synergy takes place when two or more drugs interact with each other in a way that it magnifies or enhances the effects of those drugs. The patent law of India says that the inventor can obtain protection for the new synergistic combinations of his drugs.

3. Technology Patents

These patents are related to the techniques used to resolve specific technology-based problems, including stabilization, increase in the solubility, taste masking, etc. The inventors can stop others from using the same approaches as they can claim the taste-masked formulation.

4. Polymorph Patents

Polymorphs refer to the different crystal structures or physical forms of an already known compound. Companies produce them to increase the stability or reduce the impurities of their existing compounds. These types of patents allow innovative firms to protect the improved versions of their original drugs.

5. Process Patents

Rather than claiming the products, the process patents emphasize the process of producing a particular product. Since 1960, the Indian process patent has been bestowing the inventors with the freedom to get the same product patented as long as the process used to create it is novel.

Benefits of Patents in Pharmaceutical Industry

• In the pharmaceutical industry, patents contribute to roughly 80% of the total revenue generated and is a key element defining the success of a drug manufacturer.
• Obtaining patent protection is vital to safeguard the innovative approaches used in the pharmaceutical industry.
• Patents prevent the issues of infringement by not letting the competitors easily duplicate the manufacturing of any medication or treatment.
• As developing and launching a new drug involve incredibly high costs, patents in the pharma industry help in regaining the investments that are incurred during the stage of research and development.

The Indian patent law is an example of the significant patent legislation aiming at balancing the interests of both – the consumers and the inventors. In the present times, the owners can file the Patent Application for a wide range of pharmaceutical products and processes. However, before filing, the researchers should cautiously consider the criteria of patentability and types of patents that best suit their pharmaceutical products or processes. For view source: https://www.kashishipr.com/blog/patents-in-pharmaceutical-industry-in-india/

Don’t forget to follow us on social media:

Facebook – https://www.facebook.com/kashishipr/

Twitter – https://twitter.com/kashishipr

Linkedin – https://www.linkedin.com/company/kashishipr/

Pinterest – https://www.pinterest.com/kashishipr/

Tumblr – https://kashishipr.tumblr.com/